FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21705411000001100: Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71868201000001118 Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
79996401000001119 Komboglyze 2.5mg/850mg tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Is a Saxagliptin 2.5mg / Metformin 850mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has AMP Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient Saxagliptin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start